Weimao Ding
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Liver Diseases and Immunity
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Epidemiology 19
- Liver Disease Diagnosis and Treatment 16
- Hepatitis B Virus Studies 12
- Hepatology 13
- Hepatitis C virus research 9
- Liver Diseases and Immunity 3
- Co-authors
- Chao Wu (19 shared papers)Rui Huang (19 shared papers)Xiaomin Yan (13 shared papers)Juan Xia (12 shared papers)Gang Yang (1 shared paper)Yuzhu Liu (1 shared paper)Wenhua Hou (1 shared paper)Guangming Wang (1 shared paper)
- Journals
- Journal of Hepatology (4 papers)Journal of Viral Hepatitis (3 papers)Virulence (2 papers)Scientific Reports (2 papers)Oncogene (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weimao Ding
25 papers receiving 297 citations
Peers
Comparison fields: 5 of 52
- Hepatology 106
- Epidemiology 141
- Polymers and Plastics 37
- Oncology 31
- Bioengineering 7
Countries citing papers authored by Weimao Ding
This map shows the geographic impact of Weimao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimao Ding more than expected).
Fields of papers citing papers by Weimao Ding
This network shows the impact of papers produced by Weimao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimao Ding. The network helps show where Weimao Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Weimao Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 63 | |
| 2 | 2017 | 38 | |
| 3 | 2021 | 37 | |
| 4 | 2012 | 28 | |
| 5 | 2017 | 20 | |
| 6 | 2018 | 14 | |
| 7 | 2020 | 12 | |
| 8 | 2021 | 11 | |
| 9 | 2020 | 11 | |
| 10 | 2020 | 11 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2019 | 3 | |
| 18 | 2022 | 3 | |
| 19 | The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B. | 2019 | 2 |
| 20 | 2024 | 1 |
About Weimao Ding
Weimao Ding is a scholar working on Epidemiology, Hepatology, Surgery, Nephrology and Genetics, having authored 25 papers that have together received 298 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (9 papers), Liver Diseases and Immunity (3 papers), Pancreatitis Pathology and Treatment (2 papers), Advanced Battery Materials and Technologies (1 paper), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Hepatology (106 citations), Epidemiology (141 citations), Polymers and Plastics (37 citations), Oncology (31 citations) and Bioengineering (7 citations). Weimao Ding has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Chao Wu, Rui Huang, Xiaomin Yan, Juan Xia, Gang Yang, Yuzhu Liu, Wenhua Hou, Guangming Wang, Xiaomiao Feng and Lili Xu. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, Virulence, Scientific Reports and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.